Latest Regulation News

Titan Minerals Limited has launched a transaction-specific prospectus offering 4 million new options to its underwriter, exercisable at A$0.70 and expiring in January 2027. The offer, which raises no immediate funds, could inject approximately A$2.8 million upon option exercise.

Pursuit Minerals has withdrawn its previously stated 5,000 tonnes per annum lithium production target, clarifying it was an aspirational figure not compliant with ASX rules. The company urges investors to avoid relying on this figure for investment decisions.

Anax Metals has issued a detailed clarification on its recent $3.3 million convertible note placement with Mineral Development Partners, addressing inconsistencies in shareholder approval disclosures and announcing strengthened compliance measures.

CZR Resources has secured Foreign Investment Review Board approval for the sale of its Robe Mesa Iron Ore Project, marking a significant step toward closing the A$75 million transaction.

BetMakers Technology Group reports solid Q3 FY25 financial gains alongside a strategic binding agreement to acquire Nevada’s LVDC, expanding its global racing technology footprint.

Critical Resources Limited has expanded its priority target area at the Amoco Project in NSW with rock chip samples revealing gold grades up to 15.1 g/t, alongside significant antimony and silver mineralisation.

West African Resources aligns with Burkina Faso's 2024 Mining Code, increasing the government's equity stake in its projects while maintaining its 2025 gold production targets.

PointsBet has secured a significantly improved acquisition proposal from MIXI, lifting the cash offer by 13.2% to $1.20 per share and postponing the shareholder vote to June 25. The move intensifies the takeover battle amid ongoing regulatory approvals and a rival bid from Betr Entertainment.

InhaleRx has secured swift Human Research Ethics Committee approval for its redesigned IRX-211 Phase 2 trial, expanding participant numbers and potentially bypassing Phase 3 to speed market entry.

Redivium Limited has secured a definitive five-year marketing and offtake agreement with WMC Energy BV, ensuring exclusive global sales of black mass from its UK battery recycling facility.

EVE Health Group has initiated stability testing for its novel oral treatments targeting erectile dysfunction and dysmenorrhea, marking a crucial step toward regulatory approval in Australia. The company also finalizes its acquisition of Nextract, the developer behind these innovative formulations.

Helios Energy Limited has come under ASX compliance scrutiny after late lodgement of director interest notices, raising questions about its disclosure practices and governance.